墨西哥茶苯海明市场，按处方类型（非处方药 (OTC) 和处方药）、用途（恶心、呕吐、头晕、失眠、过敏等）、给药途径（口服和肠胃外）、剂型（片剂、咀嚼片、糖浆、注射剂、其他）、产品类型（品牌、通用）、年龄（成人、老年人、儿童）、分销渠道（商店零售和在线零售）、国家（墨西哥）行业趋势和预测到 2029 年
市场分析与洞察 ：墨西哥茶苯海明市场
墨西哥茶苯海明市场预计将在 2022 年至 2029 年的预测期内获得显着增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场的复合年增长率为 2.4%，预计到 2029 年将达到 1,054.36 万美元。晕动病和过敏发病率的上升预计将推动墨西哥茶苯海明市场的增长。
茶苯海明是一种抗组胺药，用于避免和治疗儿童和成人因晕动病引起的头晕、恶心和呕吐。茶苯海明属于一类称为抗组胺药的药物。它通过预防身体平衡问题发挥作用。茶苯海明是一种抗组胺药，可减少体内的天然化学组胺。第一剂应在旅行或开始任何活动前 30 分钟至 1 小时服用，以避免晕动病。茶苯海明以乘晕药、晕车药和 gravol 的名称销售。这些茶苯海明的商品名称被用作非处方药。有时，茶苯海明也用于治疗梅尼埃病（一种导致极度头晕、失去平衡和听力丧失的内耳疾病）和其他内耳问题。
墨西哥人口中恶心、呕吐和过敏的患病率不断上升，这可能会推动墨西哥茶苯海明市场的增长。与茶苯海明药物相关的不良反应可能会阻碍市场的增长。人们对其作为非处方药的使用意识可以为促进市场需求创造机会。使用新型疗法治疗恶心可能会对墨西哥茶苯海明市场的增长构成挑战。
墨西哥茶苯海明市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报；我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
墨西哥茶苯海明 市场范围和市场规模
墨西哥茶苯海明市场根据处方类型、应用、给药途径、剂型、产品类型、年龄和分销渠道分为七个部分。
- 根据处方类型，墨西哥茶苯海明市场分为非处方药 (OTC) 和处方药。2022 年，非处方药 (OTC) 市场预计将占据市场主导地位，因为墨西哥没有关于使用 OTC 药物的具体法律，并且无法投资生产和供应茶苯海明的中型公司。我们在墨西哥的市场重点产品可用的品牌是 OTC 药物。
- 根据应用，墨西哥茶苯海明市场细分为恶心、呕吐、头晕、失眠、过敏等。由于墨西哥老年人口晕动病的增加以及晕动病治疗意识的提高，预计 2022 年恶心类药物将占据墨西哥茶苯海明市场的主导地位。
- 根据给药途径，墨西哥茶苯海明市场分为口服和肠外给药。2022 年，口服药物预计将在墨西哥茶苯海明市场占据主导地位，因为市场上提供的大多数药物都是口服片剂，因为它们易于吸收且容易获得。
- 根据剂型，墨西哥茶苯海明市场分为片剂、咀嚼片、糖浆、注射剂等。2022 年，片剂市场预计将主导墨西哥茶苯海明市场，因为它广泛可用且易于吸收。
- 根据产品类型，墨西哥茶苯海明市场分为品牌药和仿制药。2022 年，品牌药市场预计将主导墨西哥茶苯海明市场，因为这些公司提供的大多数品牌药最初都是由食品药品管理局 (FDA) 和联邦卫生风险保护委员会 (COFEPRIS) 提交的，并且被消费者广泛使用。
- 根据年龄组，墨西哥茶苯海明市场分为成人、老年人和儿童。2022 年，由于成人恶心和头晕病例增加，预计成人市场将主导墨西哥茶苯海明市场。
- 根据分销渠道，墨西哥茶苯海明市场分为实体店零售和线上零售。2022 年，实体店零售市场预计将主导墨西哥茶苯海明市场，因为与认证处方医生和健康专业人士在使用抗抑郁药方面的互动增加，并保证付款。
主要市场参与者不断增加的战略活动，以提高对茶苯海明的认识，从而促进市场增长
墨西哥茶苯海明市场还提供了每个国家在特定市场增长的详细市场分析。此外，它还提供了有关市场参与者的战略和地理分布的详细信息。数据适用于 2011 年至 2020 年的历史时期。
竞争格局和墨西哥茶苯海明市场份额分析
墨西哥茶苯海明市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对墨西哥茶苯海明市场的关注有关
墨西哥茶苯海明市场的主要参与者包括 Johnson & Johnson SA de CV、Prestige Consumer Healthcare Inc. 和 CINFA LABORATORIES（Mundipharma 的子公司）等。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
世界各地的公司也签订了许多合同和协议，进一步加速了墨西哥茶苯海明市场的增长。
例如，
- 2021 年 7 月，Prestige Consumer Healthcare 宣布已完成对 TheraTears 和其他非处方消费品牌的收购。此举有望增加该公司在美国的生产能力并有助于增加收入。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MEXICO DIMENHYDRINATE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 COUNTRY SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 CAUSE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MEXICO DEMENHYDRINATE MARKET: REGULATORY SCENARIO
5.1 KEY REGULATORY INFORMATION
5.2 GOOD MANUFACTURING PRACTICES (GMP) INSPECTION
5.3 TIMELINE TO APPROVE A DRUG
6 SUMMARY WRITE UP (MEXICO)
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF ALLERGIC DISORDER
7.1.2 INCREASE IN VULERABLE GERIATIC POPULATIONS
7.1.3 WIDE RANGE OF PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYER
7.1.4 HEALTH SECTOR REFORM AND EXPANSION OF PROGRAMMES TO BOOST HEALTHCARE SPENDING
7.1.5 IMPACT OF POLLEN ALLERGIES ON PAEDIATRICS POPULATION IN MEXICAN ATMOSPHERE
7.2 RESTRAINTS
7.2.1 SIDE EFFECTS ASSOCIATED WITH THE USE OF DIMENHYDRINATE
7.2.2 AVAILABILITY OF OTHER ANTIHISTAMINES
7.2.3 INCREASE IN TREND OF USING HOME REMEDIES/PHYTOCHEMICALS
7.3 OPPORTUNITIES
7.3.1 AWARENESS FOR USE OF OTC PRODUCTS
7.3.2 RELAXATION OF RULES ON DIRECT-TO-CONSUMER ADVERTISING
7.4 CHALLENGES
7.4.1 INCREASE IN ABUSE POTENTIAL
7.4.2 INTELLECTUAL PROPERTYY RIGHTS LAW
8 MEXICO DIMENHYDRINATE MARKET, BY PRESCRIPTION TYPE
8.1 OVERVIEW
8.2 OVER-THE-COUNTER (OTC)
8.3 PRESCRIPTION DRUGS
9 MEXICO DIMENHYDRINATE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 NAUSEA
9.2.1 NAUSEA, BY DOSAGE FORM
9.2.1.1 TABLETS
9.2.1.2 CHEWABLES
9.2.1.3 SYRUP
9.2.1.4 INJECTIONS
9.2.1.5 OTHERS
9.3 VOMITING
9.3.1 VOMITING, BY DOSAGE FORM
9.3.1.1 TABLETS
9.3.1.2 CHEWABLES
9.3.1.3 SYRUP
9.3.1.4 INJECTIONS
9.3.1.5 OTHERS
9.4 DIZZINESS
9.4.1 DIZZINES, BY DOSAGE FORM
9.4.1.1 TABLETS
9.4.1.2 CHEWABLES
9.4.1.3 SYRUP
9.4.1.4 INJECTIONS
9.4.1.5 OTHERS
9.5 INSOMNIA
9.5.1 INSOMNIA, BY DOSAGE FORM
9.5.1.1 TABLETS
9.5.1.2 CHEWABLES
9.5.1.3 SYRUP
9.5.1.4 INJECTIONS
9.5.1.5 OTHERS
9.6 ALLERGIES
9.6.1 ALLERGIES, BY DOSAGE FORM
9.6.1.1 TABLETS
9.6.1.2 CHEWABLES
9.6.1.3 SYRUP
9.6.1.4 INJECTIONS
9.6.1.5 OTHERS
9.7 OTHERS
10 MEXICO DIMENHYDRINATE MARKET, BY ROUTE OF ADMINISTRATION
10.1 OVERVIEW
10.2 ORAL
10.2.1 ORAL, BY TYPE
10.2.1.1 SWALLOW TABLETS
10.2.1.2 CHEWABLES
10.2.1.3 OTHERS
10.3 PARENTERAL
11 MEXICO DIMENHYDRINATE MARKET, BY DOSAGE FORM
11.1 OVERVIEW
11.2 TABLETS
11.3 CHEWABLES
11.3.1 CHEWABLES, BY FLAVOR
11.3.1.1 GINGER
11.3.1.2 ORANGE
11.3.1.3 GRAPE FLAVOR
11.3.1.4 OTHERS
11.4 SYRUP
11.5 INJECTIONS
11.6 OTHERS
12 MEXICO DIMENHYDRINATE MARKET, BY PRODUCT TYPE
12.1 OVERVIEW
12.2 BRANDED
12.3 GENERIC
13 MEXICO DIMENHYDRINATE MARKET, BY AGE
13.1 OVERVIEW
13.2 ADULT
13.3 GERIATRIC
13.4 CHILD
14 MEXICO DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 STORE BASED RETAIL
14.2.1 PHARMACIES AND DRUG STORES
14.2.2 SUPERMARKET/HYPERMARKET
14.2.3 HOSPITAL PHARMACIES
14.2.4 CONVENIENCE STORE
14.2.5 SPECIALITY STORES
14.2.6 OTHERS
14.3 ONLINE BASED RETAIL
15 MEXICO DIMENHYDRINATE MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MEXICO
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 JOHNSON & JOHNSON SA DE CV
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 PRESTIGE CONSUMER HEALTHCARE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.2.4.1 ACQUISITION
17.3 CINFA LABORATORIES (SUBSIDIARY OF MUNDIPHARMA)
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 MEXICO DIMENHYDRINATE MARKET, BY PRESCRIPTION TYPE, 2020-2029 (USD THOUSAND)
TABLE 2 MEXICO DIMENHYDRINATE MARKET, BY APPLICATION , 2020-2029 (USD THOUSAND)
TABLE 3 MEXICO NAUSEA IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 4 MEXICO VOMITING IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 5 MEXICO DIZZINESS IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 6 MEXICO INSOMNIA IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 7 MEXICO ALLERGIES IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 8 MEXICO DIMENHYDRINATE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD THOUSAND)
TABLE 9 MEXICO ORAL IN DIMENHYDRINATE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 MEXICO DIMENHYDRINATE MARKET, BY DOSAGE FORM , 2020-2029 (USD THOUSAND)
TABLE 11 MEXICO CHEWABLES IN DIMENHYDRINATE MARKET, BY FLAVOR, 2020-2029 (USD THOUSAND)
TABLE 12 MEXICO DIMENHYDRINATE MARKET, BY PRODUCT TYPE , 2020-2029 (USD THOUSAND)
TABLE 13 MEXICO DIMENHYDRINATE MARKET, BY AGE, 2020-2029 (USD THOUSAND)
TABLE 14 MEXICO DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 15 MEXICO STORE BASED RETAIL IN DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
图片列表
FIGURE 1 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
FIGURE 2 MEXICO DIMENHYDRINATE MARKET: DATA TRIANGULATION
FIGURE 3 MEXICO DIMENHYDRINATE MARKET: DROC ANALYSIS
FIGURE 4 MEXICO DIMENHYDRINATE MARKET: REGIONAL VS COUNTRY ANALYSIS
FIGURE 5 MEXICO DIMENHYDRINATE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MEXICO DIMENHYDRINATE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MEXICO DIMENHYDRINATE MARKET: DBMR POSITION GRID
FIGURE 8 MEXICO DIMENHYDRINATE MARKET: END USER COVERAGE GRID
FIGURE 9 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
FIGURE 10 THE SURGE IN INCIDENCE CASES OF ALLERGIES, NAUSEA AND DIZZINESS AND RISE IN PRODUCT APPPROVALS IS EXPECTED TO DRIVE THE MEXICO DIMENHYDRINATE MARKET FROM 2022 TO 2029
FIGURE 11 PRESCRIPTION TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MEXICO DIMENHYDRINATE MARKET FROM 2022 & 2029
FIGURE 12 DRIVERS, RESTRIANTS, OPPORTUNITIES, AND CHALLENGES OF MEXICO DIMENHYDRINATE MARKET
FIGURE 13 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, 2021
FIGURE 14 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, 2020-2029 (USD THOUSAND)
FIGURE 15 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, CAGR (2022-2029)
FIGURE 16 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, LIFELINE CURVE
FIGURE 17 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, 2021
FIGURE 18 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, 2020-2029 (USD THOUSAND)
FIGURE 19 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 20 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 21 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 22 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, 2020-2029 (USD THOUSAND)
FIGURE 23 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 24 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 25 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, 2021
FIGURE 26 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
FIGURE 27 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, CAGR (2022-2029)
FIGURE 28 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 29 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, 2021
FIGURE 30 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
FIGURE 31 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 32 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 33 MEXICO DIMENHYDRINATE MARKET: BY AGE, 2021
FIGURE 34 MEXICO DIMENHYDRINATE MARKET: BY AGE, 2020-2029 (USD THOUSAND)
FIGURE 35 MEXICO DIMENHYDRINATE MARKET: BY AGE, CAGR (2022-2029)
FIGURE 36 MEXICO DIMENHYDRINATE MARKET: BY AGE, LIFELINE CURVE
FIGURE 37 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 38 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
FIGURE 39 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 40 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 MEXICO DIMENHYDRINATE MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
